NCT01861938 2025-10-02
Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
Hadassah Medical Organization
Phase 2/3 Withdrawn
Clinical Trials
3 trialsNCT03070691 2017-05-05
Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)
Novartis
Phase 2/3 Withdrawn
NCT00027976 2013-08-05
Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
University of Alabama at Birmingham
Phase 2/3 Withdrawn